Hospital reports AD responsible for major reduction in C.diff cases.
AD units reduce C.diff infection rate at Sunderland Hospital
Mid-States PLC, (MST.L), is a leading environmental technology
group listed on the London Stock Exchange Alternative Investment
Market (AIM).
The acquisition of INOV8 Technologies Limited and Moving Sun Limited
in October 2006 created a leading environmental technology group
founded on proven expertise in atmospheric chemistry. Its
technologies target global concerns and interest in clean air and an
improved environment. The Mid-States Group has a suite of
sophisticated current and in-development products and is well placed
to take advantage of significant growth opportunities in its
international commercial and retail markets.
The Mid-States Group trades through its subsidiaries INOV8 Science
Limited and INOV8 Technologies Limited.
INOV8 Science specialises in air disinfection technology.
Its flagship product, the AD, is currently helping the NHS in it's
fight against airborne superbugs. For more
information please
click here.
INOV8 Technologies is a world leader in the testing and calibration
of fuel injection systems. For more information please
click here.
For more information on the history of Mid-States PLC please click here.